Multi-drug resistant tuberculosis and the red queen - Diagnosis speed is crucial;A tuberculose multirresistente e a rainha vermelha - A rapidez do diagnósticoé decisiva

Revista Portuguesa de Pneumologia

Volumn 13, Issue 6, 2007, Pages 869-877

  Costeira, João ^a   Pina, Jaime ^a  

^a HOSPITAL PULIDO VALENTE   (Portugal)

Author keywords

Genotypic method; Multi drug resistant tuberculosis; Sensitivity; Specificity

Indexed keywords

RIFAMPICIN;

AIDS PATIENT; ARTICLE; ASSAY; CONTROLLED STUDY; DATA ANALYSIS; EARLY DIAGNOSIS; GENOTYPE; HOSPITAL PATIENT; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PREDICTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 38949198305     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30381-0     Document Type: Article

References (26)

1. Youmans G P, Williston E H, Feldman W H, Hinshaw H C. Increase in resistance of tubercle bacilli to streptomycin, preliminary report. Mayo Cli 1946; 21: 126-7.
2. Sungkanuparh S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Int J Tuberc Dis 2007; 11 (3): 325-30.
3. Mitchison DA, How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc. Lung Dis 1998, 2. 10-5.
4. Mitchison DA, Nunn A J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133 (3): 423-30.
5. WHO. Treatment of Tuberculosis. Guidelines for national programmes. 3rd edn. WHO/CDS/2003.313. Geneva. World Health Organization. 2003.
6. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-6.
7. Nosocomial transmission of multi-drug resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991; 40:585-91.
8. Quy H T, Cobelens F G, Lan N T, Buu T N, Lambregts C S, Borgdorff M W. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10 (1): 45-51.
9. Chiang CY, Enarson DA, Yu MC, Bai KJ, Huang RM, Hsu CJ, SuoJ, Lin TF. Outcome of pulmonary multidrug-resistant tuberculosis: a 6 yr follow-up study. Eur Respir J 2006; 28: 980-5.
10. Sungkanuparh S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Int J Tuberc Dis 2007; 11 (3): 325-30.
11. World Health Organization, Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81:430-2.
12. Mighori G B, Ortmann J, Girardi E, Bcsozzi G, Lange C, Cirillo D M, Ferrarese M, laco, G, Gori A, Raviglione M C, and SMIRA/TBNET Study Group, Extensively Drug-resistant Tuberculosis, Italy and Germany, CDC Emerging Infectious Diseases 2007; 13:780-2.
13. Sharma SK., Mohan A., Multidrug-Resistant Tuberculosis A Menace That Threatens To Destabilize Tuberculosis Control, Chest 2006; 130:261-72.
14. Mighori G B, Loddenkemper R, Blasi F, Ravighone M C. 125 years after Robert Koch's discovery of the tubercule bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29:423-7.
15. Gandhi N R, Moll A, Sturn A W, Pavinski R, Govender T, Lallo U, Zeller K, Andrews J, Friendland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-80.
16. Nahid P, Pai M., Hopewell R, Advances in the Diagnosis and Treatment of Tuberculosis, Proc Am Thorax Soc 2006; 3:103-10.
17. Tortoli E, Palomino JC, Chapter 14 New Diagnostic Methods, Tuberculosis 2007 TuberculosisTextbook.com, First Edition, 441-86.
18. Anandi Martin and Françoise Portaels; Chapter 19: Drug Resistance and Drug Resistance Detection, Tuberculosis 2007 TuberculosisTextbook.com. First Edition, 635-60.
19. Traore, H., Deun A, Shamputa I C, Rigouts L, Portaels F. Direct Detection of Mycobacterium tuberculosis Complex DNA and Rifampin Resistance in Clinical Specimens from Tuberculosis Patients by Line Probe Assay, Journal of Clinical Microbiology 2006; 44:4384-8.
20. Viveiros M., Leandro C., Rodrigues L., Almeida J, Bettencourt R, Couto I, et al. Direct Application of the INNO-LIPA Rif.TB Line-Probe Assay for Rapid Identification of Mycobacterium tuberculosis Complex Strains and Detection Resistance in 360 Smear-Positive Respiratory Specimens from an Area of High Incidence of Multidrug-Resistant Tuberculosis, Journal of Clinical Microbiology 2005; 43:4880-4.
21. Morgan M., Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis. a systematic review and meta-analysis, BMC infectious Diseases 2005; 5:62.
22. a Reunião de Pneumologistas do Hospital Pulido Valente 2005; 83-99.
23. Kaufmann SHE, Cole ST, Mizrahi V, Rubin E, Nathan C. Mycobacterium tuberculosis and the host response. J Exp Med 2005; 6:1963-7.
24. Schluger N W. The Pathogenesis of Tuberculosis, The First One Hundred (and Twenty-Three) Years, Am J Respir Cell Mol Biol 2005; 32:251-6.
25. Van Valen L. A new evolutionary law. Evolutionary Theory 1973; 1:1-30.
26. Carrol L. 1872. Through the looking glass and what Alice found there. MacMillan, London.